These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prevalence of co-occurring autism spectrum disorder and attention deficit/hyperactivity disorder among children in the United States. Casseus M Autism; 2022 Aug; 26(6):1591-1597. PubMed ID: 35362330 [TBL] [Abstract][Full Text] [Related]
25. Parent-reported and clinician-observed autism spectrum disorder (ASD) symptoms in children with attention deficit/hyperactivity disorder (ADHD): implications for practice under DSM-5. Grzadzinski R; Dick C; Lord C; Bishop S Mol Autism; 2016; 7():7. PubMed ID: 26788284 [TBL] [Abstract][Full Text] [Related]
26. The Prevalence of Parent-Reported Autism Spectrum Disorder Among US Children. Kogan MD; Vladutiu CJ; Schieve LA; Ghandour RM; Blumberg SJ; Zablotsky B; Perrin JM; Shattuck P; Kuhlthau KA; Harwood RL; Lu MC Pediatrics; 2018 Dec; 142(6):. PubMed ID: 30478241 [TBL] [Abstract][Full Text] [Related]
27. Attention Deficit Hyperactivity Disorder Symptoms in Young Children with Autism Spectrum Disorder. Hong JS; Singh V; Kalb L Autism Res; 2021 Jan; 14(1):182-192. PubMed ID: 33073542 [TBL] [Abstract][Full Text] [Related]
28. [ADI-R and ADOS and the differential diagnosis of autism spectrum disorders: Interests, limits and openings]. Frigaux A; Evrard R; Lighezzolo-Alnot J Encephale; 2019 Nov; 45(5):441-448. PubMed ID: 31495549 [TBL] [Abstract][Full Text] [Related]
29. Dose-Response Effects of Long-Acting Liquid Methylphenidate in Children with Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study. Kim SJ; Shonka S; French WP; Strickland J; Miller L; Stein MA J Autism Dev Disord; 2017 Aug; 47(8):2307-2313. PubMed ID: 28474229 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Siafis S; Çıray O; Wu H; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; San José Cáceres A; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S Mol Autism; 2022 Mar; 13(1):10. PubMed ID: 35246237 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. ; MMWR Surveill Summ; 2014 Mar; 63(2):1-21. PubMed ID: 24670961 [TBL] [Abstract][Full Text] [Related]
32. A transdiagnostic model of psychiatric symptom co-occurrence and autism spectrum disorder. Rodriguez-Seijas C; Gadow KD; Rosen TE; Kim H; Lerner MD; Eaton NR Autism Res; 2020 Apr; 13(4):579-590. PubMed ID: 31647197 [TBL] [Abstract][Full Text] [Related]
33. Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India. Manohar H; Kuppili PP; Kandasamy P; Chandrasekaran V; Rajkumar RP Asian J Psychiatr; 2018 Mar; 33():68-73. PubMed ID: 29544110 [TBL] [Abstract][Full Text] [Related]
34. Advances in the Diagnosis and Treatment of Autism Spectrum Disorders in Children. Lin X; Wang G; Shen S; Zhan J Altern Ther Health Med; 2024 Mar; 30(3):170-175. PubMed ID: 37883758 [TBL] [Abstract][Full Text] [Related]
35. Language deficits in specific language impairment, attention deficit/hyperactivity disorder, and autism spectrum disorder: An analysis of polygenic risk. Nudel R; Christiani CAJ; Ohland J; Uddin MJ; Hemager N; Ellersgaard DV; Spang KS; Burton BK; Greve AN; Gantriis DL; Bybjerg-Grauholm J; Jepsen JRM; Thorup AAE; Mors O; Nordentoft M; Werge T Autism Res; 2020 Mar; 13(3):369-381. PubMed ID: 31577390 [TBL] [Abstract][Full Text] [Related]
36. Autism spectrum disorder phenotype and intellectual disability in females with epilepsy and PCDH-19 mutations. Breuillard D; Leunen D; Chemaly N; Auclair L; Pinard JM; Kaminska A; Desguerre I; Ouss L; Nabbout R Epilepsy Behav; 2016 Jul; 60():75-80. PubMed ID: 27179713 [TBL] [Abstract][Full Text] [Related]
37. Association of Coexisting Conditions, Attention-Deficit/Hyperactivity Disorder Medication Choice, and Likelihood of Improvement in Preschool-Age Children: A Developmental Behavioral Pediatrics Research Network Study. Deavenport-Saman A; Vanderbilt DL; Harstad E; Shults J; Barbaresi W; Bax A; Cacia J; Friedman S; LaRosa A; Loe I; Mittal S; Blum N J Child Adolesc Psychopharmacol; 2022 Aug; 32(6):328-336. PubMed ID: 35787014 [No Abstract] [Full Text] [Related]
38. School dysfunction in youth with autistic spectrum disorder in Taiwan: The effect of subtype and ADHD. Chiang HL; Kao WC; Chou MC; Chou WJ; Chiu YN; Wu YY; Gau SS Autism Res; 2018 Jun; 11(6):857-869. PubMed ID: 29427542 [TBL] [Abstract][Full Text] [Related]
39. The cost-effectiveness of treatments for attention deficit-hyperactivity disorder and autism spectrum disorder in children and adolescents: a systematic review. Sampaio F; Feldman I; Lavelle TA; Skokauskas N Eur Child Adolesc Psychiatry; 2022 Nov; 31(11):1655-1670. PubMed ID: 33751229 [TBL] [Abstract][Full Text] [Related]
40. Communication interventions for autism spectrum disorder in minimally verbal children. Brignell A; Chenausky KV; Song H; Zhu J; Suo C; Morgan AT Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012324. PubMed ID: 30395694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]